Inflammatory markers
There were no significant differences observed in the levels of inflammatory markers, including high-sensitive C-reactive protein (hs-CRP), D-dimer, presepsin, procalcitonin, ferritin, and erythrocyte sedimentation rate, on days 0, 2, 5, and 14 following treatments with both CPT-FPV and sotrovimab. However, hs-CRP levels showed a greater decrease in the sotrovimab group between days 2–5 and 0–14 (Fig. S6).